Evaluation of Functional Status, Pulmonary Capacity, Body Composition, and Quality of Life of End-Stage Liver Disease Patients Who are Candidates for Liver Surgery

Santos, Daniele Costa dos; Limongi, Vivian; Silva, A.M. de Oliveira da; Ataíde, Elaine Cristina de; Mei, M.F.T.; Udo, E.Y.; Boin, I.F.S.F.; Stucchi, Raquel Silveira Bello

doi:10.1016/j.transproceed.2014.05.043

Cited by 8 publications

(4 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A root mean square is calculated to quantify the EMG signals that are output as a function of time. 18,19,20 However, studies are limited, and thus far, the method is believed to be inefficient, given the predominance of muscle loss due to ascites and asthenia in patients with liver disease. 18 In contrast, respiratory muscle strength can be assessed by measuring maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) through manovacuometry.…”

Section: Respiratory Muscle Profilingmentioning

confidence: 99%

“…23 Although its primary indication typically revolves around studying the response of medical therapy in moderate to severe heart and lung disease, it has been recently used in determining the functional capacity of patients with liver disease and as a predictor of mortality in liver transplant candidates. 20,21,[24][25][26] Compared to healthy patients, patients with liver disease typically exhibited a shorter distance walked which was also related to the severity of liver disease. 26 This distance walked is correlated with MIP and MEP.…”

Section: Functional Capacity Testingmentioning

confidence: 99%

See 1 more Smart Citation

Intensive Care of Pulmonary Complications Following Liver Transplantation

Lui

Spaho

Holzwanger

et al. 2018

J Intensive Care Med

View full text Add to dashboard Cite

Chronic liver disease has been associated with pulmonary dysfunction both before and after liver transplantation. Post-liver transplantation pulmonary complications can affect both morbidity and mortality often necessitating intensive care during the immediate postoperative period. The major pulmonary complications include pneumonia, pleural effusions, pulmonary edema, and atelectasis. Poor clinical outcomes have been known to be associated with age, severity of liver dysfunction, and preexisting lung disease as well as perioperative events related to fluid balance, particularly transfusion and fluid volumes. Delineating each and every one of these pulmonary complications and their associated risk factors becomes paramount in guiding specific therapeutic strategies.

show abstract

Section: Respiratory Muscle Profilingmentioning

confidence: 99%

Section: Functional Capacity Testingmentioning

confidence: 99%

Intensive Care of Pulmonary Complications Following Liver Transplantation

Lui

Spaho

Holzwanger

et al. 2018

J Intensive Care Med

View full text Add to dashboard Cite

show abstract

“…9,16,17 The sum of these different factors triggers global motor impairment, sedentary lifestyle, and weight gain, negatively affecting the activities of daily living. 10,18 C), which estimates the probability of the conditional sample at marginal values.…”

Section: Discussionmentioning

confidence: 99%

Chronic Liver Disease Questionnaire as a Tool to Evaluate the Quality of Life in Liver Transplant Candidates

et al. 2018

View full text Add to dashboard Cite

Introduction: The advanced stage of liver disease causes impairments in the quality of life due to the physiological symptoms, besides the social and emotional stress. The aim of this study was to evaluate the quality of life of candidates for liver transplantation in specialized center in the interior of the state of São Paulo, Brazil. Methods: An observational study was carried out, with a quantitative approach. The sample was of convenience with the participation of 50 candidates for liver transplantation. Demographic characterization data, clinical data, and the Chronic Liver Disease Questionnaire were used to evaluate the quality of life. Results: The majority of the participants were male (68%), married (76%), with an average age of 55.7 years and average income of 2 to 3 minimum wages (42%). The main cause of liver disease was alcoholism (34%), mean time on the waiting list was 247.8 days, and mean model for end-stage liver disease was 20.5 points. The mean quality of life score was 2.9 points (standard deviation ¼ 1.0) and the analysis of the 6 domains showed greater impairment of fatigue (2.2), activity (2.7), and concern (2.9) and better evaluation of systemic symptoms (3.4) and emotion (3.3). Conclusion: Quality of life is impaired in most of the participants, indicating the need for greater attention and evaluation in the physical, mental, and social scope of this clientele.

show abstract

“…Quality of life is measured using the SF‐36 and Measuring Quality of Life at the End of Life (QUAL‐E) questionnaire. The SF‐36 is a multi‐purpose health survey with 36 questions and has been used in surveys of general and specific populations including patients with ESLD (dos Santos et al, ; Garratt, Ruta, Abdalla, & Russell, ). The SF‐36 yields an 8‐scale profile of functional health and well‐being scores as well as physical and mental health summary measures, and a preference‐based health utility index (Brazier et al, ).…”

Section: Methodsmentioning

confidence: 99%

Background and design of the symptom burden in end‐stage liver disease patient‐caregiver dyad study

Hansen

Lyons

Dieckmann

et al. 2017

Research in Nursing & Health

View full text Add to dashboard Cite

Over half a million Americans are affected by cirrhosis, the cause of end-stage liver disease (ESLD). Little is known about how symptom burden changes over time in adults with ESLD and their informal caregivers, which limits our ability to develop palliative care interventions that can optimize symptom management and quality of life in different patient-caregiver dyads. The purpose of this article is to describe the background and design of a prospective, longitudinal descriptive study, “Symptom Burden in End-Stage Liver Disease Patient-Caregiver Dyads,” which is currently in progress. The study is designed to (1) identify trajectories of change in physical and psychological symptom burden in adults with ESLD; (2) identify trajectories of change in physical and psychological symptom burden in caregivers of adults with ESLD; and (3) determine predictors of types of patient-caregiver dyads that would benefit from tailored palliative care interventions. We aim for a final sample of 200 patients and 200 caregivers who will be followed over 12 months. Integrated multilevel and latent growth mixture modeling will be used to identify trajectories of change in symptom burden, linking those changes to clinical events and quality of life outcomes and characterizing types of patient-caregiver dyads based on patient-, caregiver-, and dyad-level factors. Challenges we have encountered include unexpected attrition of study participants, participants not returning their baseline questionnaires, and hiring and training of research staff. The study will lay the foundation for future research and innovation in ESLD, end-of-life and palliative care, and caregiving.

show abstract

Evaluation of Functional Status, Pulmonary Capacity, Body Composition, and Quality of Life of End-Stage Liver Disease Patients Who are Candidates for Liver Surgery

Cited by 8 publications

References 14 publications

Intensive Care of Pulmonary Complications Following Liver Transplantation

Intensive Care of Pulmonary Complications Following Liver Transplantation

Chronic Liver Disease Questionnaire as a Tool to Evaluate the Quality of Life in Liver Transplant Candidates

Background and design of the symptom burden in end‐stage liver disease patient‐caregiver dyad study

Contact Info

Product

Resources

About